Multisystem Inflammatory Syndrome in Children (MIS-C) (DBCOND0130588)
Identifiers
- Synonyms
- MIS-C Multisystem Inflammatory Syndrome in Children
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04830852 Pediatric COVID Outcomes Study (PECOS) No drug interventions Not Available Not Available active_not_recruiting NCT05052424 Immun Response in Children With MIS-C No drug interventions Not Available Not Available unknown_status NCT04588363 COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C No drug interventions Not Available Not Available completed NCT05287412 Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children No drug interventions Not Available Not Available active_not_recruiting NCT04278404 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) - Abatacept
- Acetylsalicylic acid
- Aminocaproic acid
- Amiodarone
- Amphetamine
- Anakinra
- Azithromycin
- Bosentan
- Budesonide
- Canakinumab
- Cefdinir
- Cefepime
- Ceftazidime
- Clindamycin
- Clobazam
- Colchicine
- Dexamethasone
- Dexmedetomidine
- Fosfomycin
- Furosemide
- Gabapentin
- Guanfacine
- Hydrocortisone
- Infliximab
- Labetalol
- Lopinavir
- Meropenem
- Metformin
- Milrinone
- Nalbuphine
- Nicardipine
- Nifedipine
- Oseltamivir
- Oxycodone
- Remdesivir
- Ribavirin
- Risperidone
- Ritonavir
- Ruxolitinib
- Sarilumab
- Sertraline
- Sevelamer
- Spironolactone
- Terbutaline
- Tocilizumab
- Tranexamic acid
- Voriconazole
- Zolpidem
Not Available Not Available recruiting NCT04640038 Contrast Enhanced Ultrasound in COVID-19 diagnostic 3 completed